Today, the Ad Council and national nonprofit Futures Without Violence launched a national public service campaign called #TeachEarly highlighting the pivotal role that men play in preventing domestic and sexual violence. The campaign launch coincides with the release of the Ad Council Domestic Violence Prevention Continuous Tracking Study, which was funded by the Robert Wood Johnson Foundation. Of the men surveyed, 89 percent agreed that it’s important for men to talk to boys about violence against women and girls, while only 37 percent reported speaking to a boy they know about violence against women in the past six months. The campaign encourages men to recognize this dissonance between their beliefs and actions, and teach boys to respect women with the same enthusiasm and dedication in which they teach them other things.
To view the Multimedia News Release, go http://www.multivu.com/players/English/7482751-ad-council-domestic-violence/
A Compilation of Amazing Stories from different Christians. #1 Kamal, a Muslim fighting Jihad against America is Changed by Jesus Christ. #2 The Salvation of Guy Iannello, from Drug dealer to Christ. #3 Jeff Harshbarger, from satanism to salvation. #4 The Reality of Hell. #5 The man from George Street. #6 Escaping Demonic Oppression, by Shawn Williams. #7 A man who survived a plane crash, severely burnt, goes to heaven and sees Jesus Christ. Mickey Robinson. #8 Arctic Fire, how A northern arctic village was transformed by a visitation by Jesus. #9 The Revival Video, the state of the Christian Church. #10 The Passion of the Christ Video
Did you know that with NRMA Car insurance, you’re covered for anyone to drive your car?
With car insurance from NRMA you can enjoy cover for your car against accidental damage, collisions, crashes, fire, theft and even floods and storms.
Our comprehensive plus car insurance package also offers extra services such as unlimited car hire, if it’s been damaged or stolen. Cover starts from as little as $1.65 a day.
Get in touch today for more information or a car insurance quote.
http://www.nrma.com.au/car-insurance
Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated.
To view the multimedia release go to:
https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
Tanger Factory Outlet Centers, Inc. announced today that in honor of the 25th annual Tanger PINK Campaign it will again offer shoppers great savings in return for supporting the ongoing efforts to end breast cancer during the month of October.
Launching today at Tanger Outlets across the United States and Canada, the Tanger PINK Campaign offers shoppers using the Shop Pink Card the opportunity to receive additional savings on the best brand name and designer fashions while helping to unite in the fight against breast cancer.
To view the multimedia release go to:
https://www.multivu.com/players/English/8385651-tanger-outlets-tanger-pink-campaign-against-breast-cancer/
Federally funded research continues to spur progress against cancer; however, accelerating the pace of progress will require robust, sustained, and predictable annual funding increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Food and Drug Administration (FDA). Additionally, strong financial support for the National Cancer Moonshot Initiative is required, according to the sixth annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
One of the most exciting new approaches to cancer treatment is cancer immunotherapy. As detailed in the report, the utility of immunotherapy is expanding rapidly. For example, on Aug. 1, 2015, one class of immunotherapeutics, checkpoint inhibitors, was initially approved for just two types of cancer—melanoma and lung cancer. As of Sept. 1, 2016, checkpoint inhibitors have been approved for treating six types of cancer—bladder cancer, head and neck cancer, Hodgkin lymphoma, kidney cancer, lung cancer, and melanoma.
To view the multimedia release go to:
http://www.multivu.com/players/English/7911951-aacr-2016-cancer-progress-report/
GENESIS has unveiled its striking ‘New York Concept’ luxury sports sedan at the New York International Auto Show. The New York Concept hints at future GENESIS design direction with its expressive and refined ‘Athletic Elegance,’ first seen in the Vision G concept and in production form with the GENESIS G90 premium luxury sedan.
Acknowledging the GENESIS brand’s sporty and agile nature, the hybrid concept generates 245ps and 36.0 kgf.m of torque from its 2.0 GDi powertrain coupled with an 8-speed automatic transmission. The advanced technological features and precise design language of the concept emphasize key aspects of Korean culture, while elevating the value and perception of the GENESIS brand.
The exterior of the New York Concept presents an elegant interpretation of a luxurious performance vehicle, defined by well-balanced proportions and refined surface treatments. Inside, the concept car combines advanced technology with absolute luxury, contrasting innovative electronics against finely-crafted materials.
To view the multimedia release go to:
http://www.multivu.com/players/English/7506054-hyundai-genesis-hybrid-sports-sedan-nyias/
Diabetes initiative and the global fight against the urban diabetes epidemic. These two major metropolitan centres are the first Chinese cites to become part of the global partnership programme, which was initiated in Mexico City in March 2014, followed by Copenhagen in Europe and Houston in the United States last week.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7377451-novo-nordisk-shanghai-diabetes/
One of the most difficult realizations for those with loved ones fighting a serious illness is understanding that treatment is no longer working. No one wants to admit that it has become a losing battle against a serious illness. Many people are hesitant to call hospice for a loved one because they see it as “giving up.” In reality, contacting hospice is a choice that can lead to fewer worries and more meaningful moments during a serious illness or near the end of life.
To view the multimedia release go to:
http://www.multivu.com/players/English/7429131-moments-of-life-by-hospice/
See America, Allergan’s initiative to fight against preventable blindness in the United States, today unveiled a powerful video featuring award-winning actor and hip-hop artist Common, that urges Americans to “stand in the way of darkness”.
The video harnesses Common’s striking spoken word ability, calling on Americans to fight against vision loss and prioritize their vision. Common highlights the 61 million Americans at-risk of severe vision loss, and challenges us all to imagine a life without sight.
“I'm proud to join Allergan in the fight against preventable blindness,” said Common. “Sight is something that far too many of us take for granted. I hope our message resonates with people across the country, no matter what age or background.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8057551-common-joins-allergan-see-america-against-preventable-blindness/
On the eve of World Cancer Day 2015, amidst the ongoing cost-of-cancer-care debate, PACE (Patient Access to Cancer care Excellence), a Lilly Oncology initiative, is launching the PACE Continuous Innovation Indicators™ (CII). CII is the first evidence-based, customizable online tool to review progress against cancer over time—initially covering 12 cancer types. The purpose of the tool is to inform public policy reforms and other efforts to accelerate continuous innovation against cancer.
“We have seen tremendous progress in cancer treatment and care during the past decades, and continuous innovation, with one discovery building on another, is responsible for most of it,” said John C. Lechleiter, Ph.D., Chairman, President, and Chief Executive Officer of Eli Lilly and Company (NYSE:LLY). “To keep the momentum going, we need policies that support continuous innovation, but first we need a deeper understanding of the innovations that have occurred, and where we need to be.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7419451-eli-lilly-oncology-pace/
